Close
Patheon
Taking a More Informed Approach to Solubility Enhancement
Product Development
Author: Marshall Crew, Ph.D., VP. PDS Global Science
Sunday, March 13, 2016

Patheon Solubility Enhancement Services approaches BCS II drug substance solubility issues a fundamentally different way. By evaluating your molecule’s physiochemical characteristics in advance, we identify the solubility enhancement technologies most likely to work, before any work is done. That helps eliminate rework and worry later on — and saves you time and money. 

 

Marshall Crew, Ph.D, partners with Pharmaceutical Technology magazine to discuss optimal development programs for molecules of various solubility level, and how it affects future planning. 

 

Please complete the short form below to access this podcast.

Connect

We look forward to learning about your specific needs, please contact us.